Pærregaard M.M.a· Hartmann J.a· Vøgg O.a· Pietersen A.a· Boyd H.A.b· Raja A.A.c· Iversen K.K.a· Bundgaard H.c· Christensen A.H.a,c

Author affiliations

aDepartment of Cardiology, Herlev-Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark
bDepartment of Cardiology, The Capital Regions Unit for Inherited Cardiac Diseases, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
cDepartment of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: December 13, 2021
Accepted: March 26, 2022
Published online: July 20, 2022

Number of Print Pages: 9
Number of Figures: 2
Number of Tables: 3

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: https://www.karger.com/NEO

Abstract

Background: Previous studies have suggested an increased prevalence of congenital heart disease among children born to women aged ≥35 years. In recent decades, the mother’s age at childbirth has increased dramatically in industrialized countries. It has not been investigated if increasing maternal age affects the neonatal cardiac electrical system. Methods: The Copenhagen Baby Heart Study is a prospective general population study that performed cardiac evaluation in newborns. Electrocardiograms were analyzed with a computerized algorithm. Results: We included 16,518 newborns with normal echocardiograms (median age 11 days; range 0–30 days; 52% boys). Median maternal age at delivery was 31 years; 790 newborns were born to mothers aged between 16 and 24 years, 11,403 between 25 and 34 years, 4,279 between 35 and 44 years, and 46 newborns had mothers aged between 45 and 54 years. The QRS axis and maximum R-wave amplitude in V1 (R-V1) differed across the four maternal age groups (both p < 0.01), with absolute differences of 3.5% (114 vs. 110°) and 12% (1,152 vs. 1,015 µV), respectively, between newborns with the youngest and oldest mothers. Associations between maternal age and the QRS axis and R-V1 remained significant after multifactorial adjustment. Heart rate, PR interval, QRS duration, uncorrected QT interval, QTcBazett, and maximum amplitudes of S-V1, R-V6, and S-V6 were not associated with maternal age (all p > 0.05). Conclusion: We observed a significant association between maternal age and the neonatal QRS axis and R-V1. However, the absolute differences were relatively small and maternal age is unlikely to have a clinically significant effect on the neonatal cardiac electrical system.

© 2022 S. Karger AG, Basel

References Goetzinger KR, Shanks AL, Odibo AO, Macones GA, Cahill AG. Advanced maternal age and the risk of major congenital anomalies. Am J Perinatol. 2017;34(3):217–22. Miller A, Riehle-Colarusso T, Siffel C, Frías JL, Correa A. Maternal age and prevalence of isolated congenital heart defects in an urban area of the United States. Am J Med Genet A. 2011 Sep;155A(9):2137–45. Reefhuis J, Honein MA. Maternal age and non-chromosomal birth defects, Atlanta—1968–2000: teenager or thirty-something, who is at risk? Birt Defects Res A Clin Mol Teratol. 2004;70(9):572–9. Hollier LM, Leveno KJ, Kelly MA, Mcintire DD, Cunningham FG. Maternal age and malformations in singleton births. Obstet Gynecol. 2000 Nov;96(5):701–6. Best KE, Rankin J. Is advanced maternal age a risk factor for congenital heart disease? Birth Defects Res A Clin Mol Teratol. 2016;106(6):461–7. Baird PA, Sadovnick AD, Yee IM. Maternal age and birth defects: a population study. Lancet. 1991 Mar;337(8740):527–30. Pradat P. Epidemiology of major congenital heart defects in Sweden, 1981–1986. J Epidemiol Community Health. 1992 Jun;46(3):211–5. Sillesen A-S, Raja AA, Pihl C, Vøgg ROB, Hedegaard M, Emmersen P, et al. Copenhagen baby heart study: a population study of newborns with prenatal inclusion. Eur J Epidemiol. 2019 Jan;34(1):79–90. Ventura SJ, Martin JA, Curtin SC, Mathews TJ. Report of final natality statistics, 1996. Mon Vital Stat Rep. 1998;46(11 Suppl):1–99. Schulkey CE, Regmi SD, Magnan RA, Danzo MT, Luther H, Hutchinson AK, et al. The maternal age-associated risk of congenital heart disease is modifiable. Nature. 2015 Apr;520(7546):230–3. Chou FS, Johnson AJ, Ghimire LV. The significance of left axis deviation in the pediatric population: a meta-analysis. Pediatr Cardiol. 2019 Apr;40(4):677–84. Weissler Snir A, Gollob MH, Chauhan V, Care M, Spears DA. Evaluation of prolonged QT interval: structural heart disease mimicking long QT syndrome. Pacing Clin Electrophysiol. 2017;40(4):417–24. Hvidemose SO, Pærregaard MM, Pihl CA, Pietersen AH, Iversen KK, Bundgaard H, et al. Precordial ECG amplitudes in the days after birth: electrocardiographic changes during transition from fetal to neonatal circulation. Pediatr Cardiol. 2021 Apr;42(4):832–9. Pærregaard MM, Kock J, Pihl C, Pietersen A, Iversen KK, Bundgaard H, et al. The evolution of the neonatal QRS axis during the first four weeks of life. Neonatology. 2021 Mar;118(1):1–8. Malik S, Cleves MA, Honein MA, Romitti PA, Botto LD, Yang S, et al. Maternal smoking and congenital heart defects. Pediatrics. 2008 Apr;121(4):e810–6. Wu Y, Liu B, Sun Y, Du Y, Santillan MK, Santillan DA, et al. Association of maternal prepregnancy diabetes and gestational diabetes mellitus with congenital anomalies of the newborn. Diabetes Care. 2020 Dec;43(12):2983–90. Liu S, Joseph KS, Lisonkova S, Rouleau J, Van den Hof M, Sauve R, et al. Association between maternal chronic conditions and congenital heart defects: a population-based cohort study. Circulation. 2013 Aug;128(6):583–9. Correa A. Maternal body mass index and congenital heart defects. J Am Coll Cardiol. 2019 Jan;73(1):54–7. Lean SC, Heazell AEP, Dilworth MR, Mills TA, Jones RL. Placental dysfunction underlies increased risk of fetal growth restriction and stillbirth in advanced maternal age women. Sci Rep. 2017 Aug;7:9677. Wardinger JE, Ambati S. Placental insufficiency. StatPearls Publishing; 2020 [cited 2021 May 6]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK563171/. Care AS, Bourque SL, Morton JS, Hjartarson EP, Davidge ST. Effect of advanced maternal age on pregnancy outcomes and vascular function in the rat. Hypertension. 2015 Jun;65(6):1324–30. Barbera A, Giraud GD, Reller MD, Maylie J, Morton MJ, Thornburg KL. Right ventricular systolic pressure load alters myocyte maturation in fetal sheep. Am J Physiol Regul Integr Comp Physiol. 2000 Oct;279(4):R1157–64. Murotsuki J, Challis JR, Han VK, Fraher LJ, Gagnon R. Chronic fetal placental embolization and hypoxemia cause hypertension and myocardial hypertrophy in fetal sheep. Am J Physiol. 1997 Jan;272(1):R201–7. Louey S, Jonker SS, Giraud GD, Thornburg KL. Placental insufficiency decreases cell cycle activity and terminal maturation in fetal sheep cardiomyocytes. J Physiol. 2007 Apr;580(Pt 2):639–48. Nagasawa H, Hamada C, Wakabayashi M, Nakagawa Y, Nomura S, Kohno Y. Time to spontaneous ductus arteriosus closure in full-term neonates. Open Heart. 2016 May;3(1):e000413. Alio AP, Salihu HM, McIntosh C, August EM, Weldeselasse H, Sanchez E, et al. The effect of paternal age on fetal birth outcomes. Am J Mens Health. 2012 Sep;6(5):427–35. Article / Publication Details

First-Page Preview

Received: December 13, 2021
Accepted: March 26, 2022
Published online: July 20, 2022

Number of Print Pages: 9
Number of Figures: 2
Number of Tables: 3

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: https://www.karger.com/NEO

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.